![Alan Kozikowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan Kozikowski
Net worth: 484 605 $ as of 31/05/2024
Career history of Alan Kozikowski
Former positions of Alan Kozikowski
Companies | Position | Start | End |
---|---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | Director/Board Member | 31/05/2019 | 07/09/2022 |
Chief Tech/Sci/R&D Officer | 29/10/2020 | 27/06/2022 | |
Founder | 31/05/2019 | 07/09/2022 | |
Starwise Therapeutics LLC | Chief Executive Officer | 01/08/2017 | 01/02/2020 |
President | 01/08/2017 | 01/02/2020 | |
University of Illinois | Corporate Officer/Principal | 01/07/2013 | 31/07/2017 |
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Founder | 01/01/2015 | - |
Georgetown University Medical Center | Corporate Officer/Principal | - | - |
University of Pittsburgh | Corporate Officer/Principal | - | - |
Statistics
International
United States | 7 |
Operational
Corporate Officer/Principal | 3 |
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
Private companies | 2 |
---|---|
Starwise Therapeutics LLC | |
Actuate Therapeutics, Inc.
![]() Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Alan Kozikowski
- Experience